
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
GSK343, an Inhibitor of Enhancer of Zeste Homolog 2, Reduces Glioblastoma Progression through Inflammatory Process Modulation: Focus on Canonical and Non-Canonical NF-κB/IκBα Pathways
Sarah Adriana Scuderi, Alessia Filippone, Rossella Basilotta, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13915-13915
Open Access | Times Cited: 17
Sarah Adriana Scuderi, Alessia Filippone, Rossella Basilotta, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13915-13915
Open Access | Times Cited: 17
Showing 17 citing articles:
ROS regulation in gliomas: implications for treatment strategies
Yuchen Yang, Yu Zhu, Si-Jia Sun, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Yuchen Yang, Yu Zhu, Si-Jia Sun, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
The duality of CXCR3 in glioblastoma: unveiling autocrine and paracrine mechanisms for novel therapeutic approaches
Travis Yui Hei Chan, Jenny Sum Yee Wong, Karrie Mei-Yee Kiang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 12
Travis Yui Hei Chan, Jenny Sum Yee Wong, Karrie Mei-Yee Kiang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 12
First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking Antiglioblastoma Activity In Vitro and In Vivo
Sachin Sharma, Shao‐An Wang, Wen‐Bin Yang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 4, pp. 2963-2985
Open Access | Times Cited: 4
Sachin Sharma, Shao‐An Wang, Wen‐Bin Yang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 4, pp. 2963-2985
Open Access | Times Cited: 4
EZH2–STAT3 signaling pathway regulates GSDMD-mediated pyroptosis in glioblastoma
Dong Yu, Shuai Wang, Jiajun Wang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Dong Yu, Shuai Wang, Jiajun Wang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Randomly methylated β-cyclodextrin improves water – Solubility, cellular protection and mucosa permeability of idebenone
Federica De Gaetano, Deborah Mannino, Consuelo Celesti, et al.
International Journal of Pharmaceutics (2024), pp. 124718-124718
Open Access | Times Cited: 4
Federica De Gaetano, Deborah Mannino, Consuelo Celesti, et al.
International Journal of Pharmaceutics (2024), pp. 124718-124718
Open Access | Times Cited: 4
KRAS–SOS-1 Inhibition as New Pharmacological Target to Counteract Anaplastic Thyroid Carcinoma (ATC)
Deborah Mannino, Rossella Basilotta, Fabiola De Luca, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2579-2579
Open Access
Deborah Mannino, Rossella Basilotta, Fabiola De Luca, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2579-2579
Open Access
Validation of an LC-MS/MS Method for the Simultaneous Intracellular Quantification of the CDK4/6 Inhibitor Abemaciclib and the EZH2 Inhibitors GSK126 and Tazemetostat
Stefan Senekowitsch, Thomas Freitag, Daniel Dubinski, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 433-433
Open Access
Stefan Senekowitsch, Thomas Freitag, Daniel Dubinski, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 433-433
Open Access
Combined inhibition of EZH2 and CDK4/6 perturbs endoplasmic reticulum-mitochondrial homeostasis and increases antitumor activity against glioblastoma
Thomas Freitag, Philipp Kaps, Justus Ramtke, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 3
Thomas Freitag, Philipp Kaps, Justus Ramtke, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 3
Pentraxin 3: A Main Driver of Inflammation and Immune System Dysfunction in the Tumor Microenvironment of Glioblastoma
Sarah Adriana Scuderi, Alessio Ardizzone, Ayomide Eniola Salako, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1637-1637
Open Access | Times Cited: 2
Sarah Adriana Scuderi, Alessio Ardizzone, Ayomide Eniola Salako, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1637-1637
Open Access | Times Cited: 2
Neuroprotective effects of GSK-343 in an in vivo model of MPTP-induced nigrostriatal degeneration
Deborah Mannino, Sarah Adriana Scuderi, Giovanna Casili, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Deborah Mannino, Sarah Adriana Scuderi, Giovanna Casili, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Study on the Effect of EZH2 Inhibitor Combined with TIGIT Monoclonal Antibody against Multiple Myeloma Cells
Zhaoyun Liu, Yue Jia, Chun Yang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8603-8603
Open Access | Times Cited: 4
Zhaoyun Liu, Yue Jia, Chun Yang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8603-8603
Open Access | Times Cited: 4
The Protective Role of Troxerutin (Trox) in Counteracting Anaplastic Thyroid Carcinoma (ATC) Progression
Valentina Bova, Rossella Basilotta, Giovanna Casili, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1755-1755
Open Access | Times Cited: 1
Valentina Bova, Rossella Basilotta, Giovanna Casili, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1755-1755
Open Access | Times Cited: 1
EZH2 Inhibition to Counteract Oral Cancer Progression through Wnt/β-Catenin Pathway Modulation
Michela Campolo, Sarah Adriana Scuderi, Alessia Filippone, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1102-1102
Open Access | Times Cited: 1
Michela Campolo, Sarah Adriana Scuderi, Alessia Filippone, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1102-1102
Open Access | Times Cited: 1
Gut Aging: A wane from the normal to repercussion and Gerotherapeutic strategies
Joseph Kofi Abankwah, Ying Wang, Jida Wang, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e37883-e37883
Open Access | Times Cited: 1
Joseph Kofi Abankwah, Ying Wang, Jida Wang, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e37883-e37883
Open Access | Times Cited: 1
SAL protects endothelial cells from H2O2-induced endothelial dysfunction: Regulation of inflammation and autophagy by EZH2
Sun Li, Xuefang Li, Jie Zhang, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113060-113060
Open Access
Sun Li, Xuefang Li, Jie Zhang, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113060-113060
Open Access
Chemokine signaling in tumors: potential role of CXC chemokines and their receptors as glioblastoma therapeutic targets
Alessandro Corsaro, Beatrice F. Tremonti, Adriana Bajetto, et al.
Expert Opinion on Therapeutic Targets (2024), pp. 1-16
Closed Access
Alessandro Corsaro, Beatrice F. Tremonti, Adriana Bajetto, et al.
Expert Opinion on Therapeutic Targets (2024), pp. 1-16
Closed Access
Regulation of autophagy and cellular signaling through non-histone protein methylation
Yongfen Bao, Yaoyao Ma, Wentao Huang, et al.
International Journal of Biological Macromolecules (2024), pp. 139057-139057
Closed Access
Yongfen Bao, Yaoyao Ma, Wentao Huang, et al.
International Journal of Biological Macromolecules (2024), pp. 139057-139057
Closed Access